China Pharma Holdings, Inc. (CPHI): Price and Financial Metrics
GET POWR RATINGS... FREE!
CPHI Stock Summary
- CPHI has a market capitalization of $5,422,466 -- more than approximately just 1.35% of US stocks.
- Of note is the ratio of CHINA PHARMA HOLDINGS INC's sales and general administrative expense to its total operating expenses; 98.08% of US stocks have a lower such ratio.
- CHINA PHARMA HOLDINGS INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -64.95%, greater than the shareholder yield of only 8.53% of stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to CHINA PHARMA HOLDINGS INC are ICL, FMS, YAYO, SPB, and FSM.
- Visit CPHI's SEC page to see the company's official filings. To visit the company's web site, go to www.chinapharmaholdings.com.
CPHI Valuation Summary
- In comparison to the median Healthcare stock, CPHI's price/sales ratio is 85.42% lower, now standing at 0.7.
- Over the past 169 months, CPHI's EV/EBIT ratio has gone down 6.6.
Below are key valuation metrics over time for CPHI.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| CPHI | 2022-11-25 | 0.7 | 1.9 | -1.5 | -4.4 |
| CPHI | 2022-11-23 | 0.7 | 1.9 | -1.5 | -4.4 |
| CPHI | 2022-11-22 | 0.7 | 1.9 | -1.4 | -4.4 |
| CPHI | 2022-11-21 | 0.6 | 1.7 | -1.3 | -4.3 |
| CPHI | 2022-11-18 | 0.7 | 1.9 | -1.5 | -4.5 |
| CPHI | 2022-11-17 | 0.7 | 2.1 | -1.6 | -4.6 |
CPHI Growth Metrics
- Its 2 year revenue growth rate is now at -8.93%.
- The 3 year price growth rate now stands at -35.31%.
- The 4 year net cashflow from operations growth rate now stands at -90.55%.
The table below shows CPHI's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-09-30 | 8.07246 | -1.192251 | -3.689376 |
| 2022-06-30 | 8.085156 | -1.86222 | -3.725272 |
| 2022-03-31 | 8.887559 | -0.852361 | -3.661639 |
| 2021-12-31 | 9.641925 | -0.249838 | -3.399476 |
| 2021-09-30 | 9.683661 | 0.283142 | -3.627794 |
| 2021-06-30 | 10.1057 | 0.5096 | -3.811021 |
CPHI's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- CPHI has a Quality Grade of C, ranking ahead of 56.06% of graded US stocks.
- CPHI's asset turnover comes in at 0.493 -- ranking 88th of 677 Pharmaceutical Products stocks.
- DRNA, ONVO, and CASI are the stocks whose asset turnover ratios are most correlated with CPHI.
The table below shows CPHI's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.493 | 0.094 | -0.236 |
| 2021-03-31 | 0.538 | 0.177 | -0.174 |
| 2020-12-31 | 0.495 | 0.180 | -0.168 |
| 2020-09-30 | 0.494 | 0.153 | -1.332 |
| 2020-06-30 | 0.407 | 0.183 | -0.990 |
| 2020-03-31 | 0.306 | 0.105 | -0.802 |
CPHI Stock Price Chart Interactive Chart >
CPHI Price/Volume Stats
| Current price | $0.10 | 52-week high | $0.67 |
| Prev. close | $0.11 | 52-week low | $0.09 |
| Day low | $0.10 | Volume | 62,036 |
| Day high | $0.11 | Avg. volume | 226,931 |
| 50-day MA | $0.13 | Dividend yield | N/A |
| 200-day MA | $0.24 | Market Cap | 5.27M |
Latest CPHI News From Around the Web
Below are the latest news stories about CHINA PHARMA HOLDINGS INC that investors may wish to consider to help them evaluate CPHI as an investment opportunity.
Do investors need to be concerned about China Pharma Holdings Inc. (CPHI)?A share of China Pharma Holdings Inc. (AMEX:CPHI) closed at $0.15 per share on Wednesday, up from $0.13 day before. While China Pharma Holdings Inc. has overperformed by 20.16%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, CPHI fell by -72.53%, with highs and lows ranging […] |
China Pharma Announces Receipt of Notification of NYSE American Listing DeficiencyChina Pharma Holdings, Inc. (NYSE American: CPHI; the "Company") today announced that on September 26, 2022, the Company received notification (the "Deficiency Letter") from the NYSE AMERICAN LLC ("NYSE American") informing it that the Company is not in compliance with certain NYSE American continued listing standards (the "Listing Standards"). The Deficiency Letter indicated that the Company's securities had been selling for a low price per share for a substantial period of time and, most recen |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time for an overview of the biggest pre-market stock movers for Thursday and all the news behind this morning's movement. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayWe're starting Wednesday with an overview of the biggest pre-market stock movers this morning and the news moving those shares! |
China Pharma Announced the Submission of a Plan of Compliance to NYSE AmericanChina Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that on July 15, 2022, the Company submitted a plan of compliance to NYSE American LLC ("NYSE American" or the "Exchange") to address the deficiency in the Company's stockholders' equity as pointed out in the letter from the Exchange dated June 15, 2022 (the "Letter"). |
CPHI Price Returns
| 1-mo | -23.66% |
| 3-mo | -47.70% |
| 6-mo | -60.78% |
| 1-year | -81.48% |
| 3-year | -56.73% |
| 5-year | -44.44% |
| YTD | -79.28% |
| 2021 | 8.25% |
| 2020 | 88.26% |
| 2019 | -7.86% |
| 2018 | 42.78% |
| 2017 | -30.77% |
Continue Researching CPHI
Want to do more research on China Pharma Holdings Inc's stock and its price? Try the links below:China Pharma Holdings Inc (CPHI) Stock Price | Nasdaq
China Pharma Holdings Inc (CPHI) Stock Quote, History and News - Yahoo Finance
China Pharma Holdings Inc (CPHI) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...